Spinal Elements Reports Expansion of MIS Ultra™ Offering with the Full Market Release of the Lucent® XP Wide Expandable Device for MIS TLIF

Spinal Elements, a spine technology company, today announced the newest introduction in its MIS Ultra™ suite of products with the full release of the Lucent® XP Wide expandable interbody device. This addition to Spinal Elements’ expandable interbody portfolio offers surgeons a wider footprint option than previously available and is designed with an anatomically oriented lordotic angle.

Spinal Elements notes the system is optimized to be used in MIS TLIF (transforaminal lumbar interbody fusion) procedures, but can also be used in open TLIF procedures.

With this expanded commercial release, Spinal Elements adds to the increasing number of procedural solutions within their MIS Ultra platform of products. The company’s line of expandable devices has shown rapid adoption and growth over the past year, and the company plans on further line additions to the Lucent XP offering, as well as other expandable interbody technologies to complement the MIS Ultra platform.

The Lucent XP Wide System is an interbody device with an anatomically oriented lordotic design that can expand in height and increase in lordosis after implantation. The height expansion helps restore the height of the disc space, while the lordotic angle helps correct the natural curvature of the spine. With the Lucent XP Wide device, surgeons can achieve up to 15 degrees of lordotic angle, while helping to improve spinal stability and alignment.

In addition, the Lucent XP Wide system is the only available expandable device that it is made primarily of polyetheretherketone (PEEK) and features Spinal Elements’ Ti-Bond® porous titanium coating. Ti-Bond is a hydrophilic porous titanium coating with nano-scale surface features that has been used in tens of thousands of Spinal Elements fusion procedures dating back to 2012.

Orthopedic Spine Surgeon and designer, Paul Kim, MD of the Spine Institute of San Diego, CA, says of the Lucent XP Wide System: “With oblique lordosis in the design, I am able to achieve expansion and lordosis in the midline, instead of asymmetrical lordosis. The system also allows me to place a large TLIF cage in a narrow corridor in patients with a collapsed disc without disruption of the exiting nerve root. I am a big believer in MIS TLIF and this system addresses some of the challenges that can be seen in these surgeries.”

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.